Hepatitis C viremic donors for hepatitis C nonviremic liver transplant recipients: Ready for prime time?

E-ISSN： 1527-6473|24|1|12-14

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.24, Iss.1, 2018-01, pp. : 12-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 11, 2015-11 ,pp. : 2442-2447

John Wiley & Sons Inc

Access to resources Recommend Favorite

The corrected donor age for hepatitis C virus–infected liver transplant recipients

LIVER TRANSPLANTATION, Vol. 21, Iss. 8, 2015-08 ,pp. : 1022-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir and simeprevir for treatment of hepatitis C virus infection in liver transplant recipients

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 823-830

John Wiley & Sons Inc

Access to resources Recommend Favorite

Post‐transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 8, 2015-08 ,pp. : 980-989

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus–coinfected liver transplant recipients

LIVER TRANSPLANTATION, Vol. 21, Iss. 2, 2015-02 ,pp. : 272-274

John Wiley & Sons Inc

Access to resources Recommend Favorite